Thinking about freezing your eggs to have a baby later? Here are three numbers to help you decide
Egg freezing is promoted as an empowering option for women who want to stop the biological clock and improve their chance of having a baby later in life. But they need to know it’s more like a lottery than an insurance policy.
Funding boost for early career researchers
More than $3.5 million has been awarded to eight Medicine, Nursing and Health Sciences researchers in the latest round of funding announced by the Australian Research Council.
US$5.2M joint grant will enable world’s largest study of Alzheimer’s blood tests
Dementia epidemiologist A/Prof Joanne Ryan from the School of Public Health and Preventive Medicine is one of three leaders on a US $5.2 million multiple principal investigator grant from the US National Institutes of Health, that will enable the
Providing feedback to GPs: an effective solution to overuse of musculoskeletal diagnostic imaging
A simple audit and feedback mechanism can successfully reduce overuse of musculoskeletal imaging by GPs at a national scale, saving precious health system resources, and saving patients’ time, money, potential for incidental findings,
Women’s Health Week: Breaking down the barriers to abortion access in Australia
For Women’s Health Week, Lens speaks to Professor Danielle Mazza, Monash’s Chair of General Practice, about the challenges that remain for women seeking an abortion in Australia, and what can be done to help.
5 virus families that could cause the next pandemic, according to the experts
Authorities have been warned about five virus families that could cause future pandemics. Here are snapshots of the diseases each can cause and why we should be worried.
MRFF grants to support Monash research into COVID-19
Three Monash University projects have received $10.8 million from the Medical Research Future Fund to support research that improves our understanding of COVID-19 and help develop new and enhanced treatments.
Strongest evidence yet shows negligible increase in melanoma risk from methotrexate
A new meta-analysis shows that the widely-used anti-inflammatory methotrexate has a negligible effect on the risk of developing melanoma, essentially a 0.005 per cent risk increase for Australians using the drug. The findings allay growing concerns
MRFF windfall supports integration of two major Melbourne-based COVID-19 trials
Just shy of $4 million has today been awarded to the REMAP-CAP from the Medical Research Future Fund, expanding the trial’s capacity to identify safe and effective treatments for critically ill patients with community-acquired pneumonia.